Total Company Value: Celularity (CELU)
Market fluctuations in Celularity Inc. (CELU) share prices on the GURU.Markets platform illustrate the company's strategy to create barriers to entry through exclusive access to placental biomaterials. The current Enterprise Value stands at 94.88, which, against a backdrop of zero profit and reliance on investment, underscores the testing stage. In the future, innovations in tissue regeneration could provide the business with significant pricing power.
Celularity (CELU) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Celularity Inc. (CELU)
Enterprise Value determines the total acquisition cost of a business by combining market capitalization with net debt. This metric adjusts the market value based on the volume of available cash and liabilities. The price action of Celularity Inc. (CELU), accounting for cash and debt, reveals the company's real financial weight. In the biotech sector, this balance is critical, as liquidity shortages limit partnerships. This allows an investor to see whether the debt load offsets the value of cellular developments.
Competitor analysis for Celularity Inc.
argenx N.V. - Total Enterprise Value|BNTX - Total Company Value|Abivax Pharma (ABVX) - Total Company Value|ADMA: Real Price to Acquire Entire Company|PTGX (protagonist-inc.com) - Enterprise Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|ENGN: Enterprise Value|RAPT - Real Price to Acquire Entire Company|Enterprise Value JBIO|ACRS (aclaristx.com) - Total Enterprise Value|Total Company Value Kyverna Therapeutics, Inc.|Total Company Value Tiziana Life Sciences Ltd. (TLSA)|Real Price to Acquire Entire Company CABA|Enterprise Value VTYX (Ventyx Biosciences, Inc)|Total Company Value Theratechnologies Inc. THTX|Total Company Value avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value|AGEN: Enterprise Value|Total Company Value Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Value Adjusted for Debt and Cash|ATYR: Enterprise Value|Company Buyout Price Adagene Corp (ADAG)|Real Price to Acquire Entire Company ImageneBio Inc|Aggregate Business Value shattucklabs.com STTK|EQ: Real Price to Acquire Entire Company|CNTB - Total Enterprise Value|Real Price to Acquire Entire Company Immunic Inc (IMUX)|ATRA - Value Adjusted for Debt and Cash|inflarx.de - Enterprise Value|XFOR (X4 Pharmaceuticals Inc.) - Company Buyout Price|Total Company Value Adicet Bio Inc. (ACET)|Business Value INmune Bio Corporation|Enterprise Value BRNS (Barinthus Biotherapeutics)|Real Price to Acquire Entire Company kezarlifesciences.com KZR|Real Price to Acquire Entire Company SABS|Company Buyout Price Akari Therapeutics PLC AKTX|ENLV: Enterprise Value|QTTB - Real Price to Acquire Entire Company|Enterprise Value GOVX|EDSA (edesabiotech.com) - Total Enterprise Value|Total Company Value iBio|Total Company Value Carisma Tx (CARM)|Real Price to Acquire Entire Company XTLB|Enterprise Value BOLT (boltbio.com)|HCW Biologics (HCWB) - Total Company Value|Full Business Value Aptevo Therapeutics, Inc. APVO|Enterprise Value AIM ImmunoTech Inc. (AIM)|ADTX - Value Adjusted for Debt and Cash|GRI: Enterprise Value|XRTX (XORTX Corp) - Enterprise Value|HIND - Total Company Value|Value Adjusted for Debt and Cash REVB|Total Company Value INDP (Indaptus Therapeutics, Inc.)|Real Price to Acquire Entire Company Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CALI (CalciMedica)|AFMD - Enterprise Value|Real Price to Acquire Entire Company Allakos Therapeutics (ALLK)|HOOK - Value Adjusted for Debt and Cash|igmbio.com - Enterprise Value|ITOS (iTeos Therapeutics Inc) - Company Buyout Price|Total Company Value OCEA|Real Price to Acquire Entire Company TCBP|Total Company Value THRD (Third Harmonic Bio)